Medical Oncology

Doç. Dr. Gülcan Bulut

Doctor and researcher Medicana International İzmir İzmir
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicana.com.tr.

  • Kanser tedavisi
  • Kemoterapi
  • İmmünoterapi ve
  • Kişiselleştirilmiş tedaviler

CV

Education and experience

From source

Experience

  • 2007-2012Araştırma Görevlisi-Ege Üniversitesi Tıp Fakültesi, İç Hastalıkları ADmedicana.com.tr
  • 2012-2013Araştırma Görevlisi-Celal Bayar Üniversitesi Tıp Fakültesi, İç Hastalıkları AD, Tıbbi Onkoloji BDmedicana.com.tr
  • 2013-2016Araştırma Görevlisi-Ege Üniversitesi Tıp Fakültesi, İç Hastalıkları AD, Tıbbi Onkoloji BDmedicana.com.tr
  • 2017-2019Uzman Tabip-Kahramanmaraş Necip Fazıl Şehir Hastanesi, Tibbi Onkoloji BDmedicana.com.tr
  • 2019-2021Uzman Tabip-Hatay Özel Defne Hastanesi, Tibbi Onkoloji BDmedicana.com.tr

Education

  • 2006Ege Üniversitesi Tıp Fakültesimedicana.com.tr
  • 2012Tıpta Uzmanlık-Ege Üniversitesi Tıp Fakültesi-İç Hastalıklarımedicana.com.tr
  • 2016Yan Dal Uzmanlık-Ege Üniversitesi Tıp Fakültesi-Onkolojimedicana.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologymedicana.com.trFrom source
  • Department name at the sourceMedikal Onkolojimedicana.com.trFrom source
  • InstitutionMedicana International İzmirmedicana.com.trFrom source
  • Publications33 publicationsmedicana.com.tr profile pageFrom source
  • Last synchronised7 November 2026 03:18https://www.medicana.com.tr/hekim-detay/12790/gulcan-bulutmedicana.com.tr

Scientific work

Publications

33 publications

  1. M-761-5663 YILDIRIM SERKAN, BULUT GÜLCAN (2022). Metastatik mide kanserinde karsinoembriyonik antijen (cea) prediktif midir?. Ege Tıp Dergisi, 61(1), 99-104.,Doi: 10.19161/etd.1086149 M-733-0912 BULUT GÜLCAN, ATMACA İLHAN HARİKA, KARACA BURÇAK (2021). Palbosiklib’in triple negatif meme kanseri hücre hatları(MDA-MB-231 ve MDA-MB-468) üzerine sitotoksik etkisi. Dicle Tıp Dergisi, 48(4), 806-814., Doi: 10.5798/dicletip.1037795

    Source: medicana.com.tr profile page

  2. M-763-1405 BULUT GÜLCAN, USLU RÜÇHAN, EYİGÖR CAN, UYAR MELTEM (2017). Palyatif bakımda semptom yönetimi (dispne, yorgunluk, bulantı-kusma, ağrı). Türkiye Klinikleri Journal of Anesthesiology Reanimation - Specieal Topics, 10(1), 25-35. M-763-1396 BULUT GÜLCAN, USLU RÜÇHAN (2016). Evre III B over karsinom olgusu. Türkiye Klinikleri Journal of Medical Oncology - Special Topics, 9(1), 14-15. M-163-9844 YAPRAK MUSTAFA,TURAN MEHMET NURİ,TAMER ABDÜLKERİM FURKAN,TATAR ERHAN,BULUT GÜLCAN,SEZİŞ DEMİRCİ MELTEM,ÖZKAHYA MEHMET,BAŞCI ALİ (2013). Periton diyalizi hastasında acil hemodiyaliz gereksinimi; Laksatif kullanımına bağlı hipermagnezemi: Olgu sunumu. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, 22(1), 111-113., Doi: 10.5262/tndt.2013.1001.17

    Source: medicana.com.tr profile page

  3. M-763-1369 BULUT GÜLCAN, NARLI ÖZDEMİR ZEHRA (2022). Prognostic significance of Neutrophil?Lymphocyte ratio and Platelet?Lymphocyte ratio in metastatic colorectal cancer. Journal of Gastrointestinal Cancer, 53(1), 1-6., Doi: 10.1007/s12029-021-00616-y M-763-1341 YILDIRIM SERKAN, ERDOĞAN ATİKE PINAR, KARATEKE MURAT, YILMAZ CENGİZ, ÖZVEREN AHMET, BULUT GÜLCAN, EKİNCİ FERHAT, MURADOVA ELVINA (2022). Metastatic pancreatic cancer second-line treatment options: Is the difference only in cost?. Journal of Gastrointestinal Cancer, 53(1), 41-44., Doi: 10.1007/s12029-020-00573-y

    Source: medicana.com.tr profile page

  4. M-758-3825 BULUT GÜLCAN, NARLI ÖZDEMİR ZEHRA (2022). Significance of Neutrophil-Lymphocyte ratio and Trombocyte-Lymphocyte ratio in predicting complete pathological response in patients with local advanced breast cancer. Eurasian Journal of Medical Investigation, 6(1), 78-83., Doi: 10.14744/ejmi.2022.32029 M-764-8851 BULUT GÜLCAN, ÖZVEREN AHMET, EKİNCİ FERHAT, YILMAZ CENGİZ, YILDIRIM SERKAN, ERDOĞAN ATİKE PINAR (2022). Predictive value of Lymphocyte-related blood parameters of before Ado-Trastuzumab Emtansin treatment in breast cancer. Eurasian Journal of Medicine and Investigation, 26(2), 259-265., Doi: 10.14744/ejmi.2022.10130 M-763-1353 GÜNER OYTUN MERVE, BULUT GÜLCAN, GÖKMEN ERHAN (2022). Is the effect of tumor localization on prognosis compatible with real?life data in metastatic colon cancer? Single?center experience: A retrospective analysis. Journal of Gastrointestinal Cancer, 53(1), 7-15., Doi: 10.1007/s12029-021-00615-z

    Source: medicana.com.tr profile page

  5. M-710-2118 BAHÇECİ AYKUT, PAYDAŞ SEMRA, AK NAZİYE, FERHATOĞLU FERHAT, Saip Pınar Mualla, SEYDAOĞLU GÜLŞAH, BİLİCİ MEHMET, ŞİMŞEK MELİH, TEKİN SALİM BAŞOL, ÇALIKUŞU ZÜLEYHA, YAVUZ SİNAN, ŞAHİN AHMET BİLGEHAN, ÇUBUKÇU ERDEM, EVRENSEL TÜRKKAN, DEĞİRMENCİOĞLU SERKAN, DEMİRAY ATİKE GÖKÇEN, YUMUK PERRAN FULDEN, ALAN ÖZKAN, ÇIKMAN DUYGU İLKE, DEMİRELLİ FUAT HULUSİ, KÖSTEK OSMAN, GÖKYER ALİ, DOĞAN MUTLU, BAL ÖZNUR, ÇAKAR BURCU, GÖKMEN ERHAN, YAMAÇ DENİZ, KORKMAZ TANER, Aliyev Altan, KESKİN ÖZGE, URVAY SEMİHA, BÜYÜKŞİMŞEK MAHMUT, KARADENİZ CEMİLE, YILDIZ BİROL, YEŞİL ÇINKIR HAVVA, DEMİR HACER, BEYPINAR İSMAİL, KARAÇİN CENGİZ, ESER KADİR, BAYKARA MELTEM, KILIÇKAP SAADETTİN, OKUTUR SADİ KEREM, BULUT GÜLCAN, ALKAN ALİ, ARPACI ERKAN, PİLANCI KEZBAN NUR, DEMİR ATAKAN, IŞIK DENİZ, YILDIRIM NİLGÜN (2021). Efficacy and safety of trastuzumab emtansine in Her2 positive metastatic breast cancer: Realworld experience. Cancer Investigation, 39(6), 473-481., Doi: 10.1080/07357907.2021.1933011 (Çeyreklik Dili

    Source: medicana.com.tr profile page

  6. M-717-7566 YILDIRIM SERKAN, ERDOĞAN ATİKE PINAR, YILMAZ CENGİZ, ÖZVEREN AHMET, EKİNCİ FERHAT, BULUT GÜLCAN (2021). Pancreatic cancer patients who cannot undergo curative surgery live as much as patients over 70 years old. Journal of BUON, 26(4), 1607-1611. M-761-5594 BULUT GÜLCAN, GÜNER OYTUN MERVE, MURADOVA ELVINA, DOĞU BURCU BALAM, KARACA BURÇAK (2021). Breast cancer in women aged 75 years and older. European Journal of Geriatrics and Gerontology, 3(2), 117-123., Doi: 10.4274/ejgg.galenos.2020.413

    Source: medicana.com.tr profile page

  7. M-746-1396 YILDIRIM SERKAN, ERDOĞAN ATİKE PINAR, ÖZVEREN AHMET, EKİNCİ FERHAT, BULUT GÜLCAN (2021). Evaluation of castration-resistant elderly patients. Eurasian Journal of Medical Investigation, 5(2), 251-255., Doi: 10.14744/ejmi.2021.66973 M-764-4193 GÜNER OYTUN MERVE, BULUT GÜLCAN, GÖKMEN ERHAN, DOĞU BURCU BALAM, KARABULUT BÜLENT (2021). Older adults with colon cancer are not different from younger ones, but treated differently: Retrospective analysis from single centre. Journal of Oncology Pharmacy Practice, 1-8., Doi: 10.1177/10781552211002912 (Çeyreklik Dilim=Q4)

    Source: medicana.com.tr profile page

  8. 30716122338-1034.17 29/03/2022 21:30:01Basım Tarihi : Sayfa: 2

    Source: medicana.com.tr profile page

  9. M-741-7990 BULUT GÜLCAN, GÜNER OYTUN MERVE, Almuradova Elvina, HARMAN MUSTAFA, USLU RÜÇHAN, KARABULUT BÜLENT (2021). Contribution of “complete response to treatment” to survival in patients with unresectable metastatic colorectal cancer: A retrospective analysis. PLOS ONE, 16(11), 1-13., Doi: 10.1371/journal.pone.0259622 (Çeyreklik Dilim=Q2)

    Source: medicana.com.tr profile page

  10. M-761-5678 BULUT GÜLCAN, ATMACA İLHAN HARİKA, KARACA BURÇAK (2020). Trastuzumab in combination with AT-101 induces cytotoxicity and apoptosis in Her2 positive breast cancer cells. Future Oncology, 16(3), 4485-4495., Doi: 10.2217/fon-2019-0521 (Çeyreklik Dilim=Q3)

    Source: medicana.com.tr profile page

View all 33 publications